Daewoong Pharmaceutical and Medytox focusing on taking superiority in global market aside from the legal suit
Having conflicts over the botulinum toxin strain issue, Daewoong Pharmaceutical and Medytox are going on a new direction.
Thinking ‘taking a step backward is losing; so far, they have taken a ‘truth or dare’ game with the ‘legal war’ which revealed their weak points, but both of them have now st...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.